- Idea/Basic Decision
- Declaration Regarding Patients' Rights and Responsibilities
- Message From the Director
-
Department of Clinical Laboratory
Department of Medical Supplies
Department of Blood Transfusion Service
Department of Pathology and Laboratory Medicine
Department of Emergency and Critical Care Medicine
Emergency and Medical Intensive Care Unit
Department of Blood Purification
Center for Maternal - Neonatal Care
Center of National University Hospital for Infection Control
Center for Advanced Medicine and Clinical Research
Department of Clinical Oncology and Chemotherapy
Department of Clinical Engineering
Center for Postgraduate Clinical Training and Career Development
- Idea, Basic Decision, History
- Organization Chart of University Hospital
- Organization Chart of Administration Office
- Chronological List of Directors of University Hospital
- Established Date of Clinical Departments
- Clinical Departments
- Legal Authorization of Medical Services
- University Hospital Staff, Number of Staffs
- Number of Beds
- Patient Services in the University Hospital in 2011
- Clinical Indicator
- Access
Profile of Nagoya University Hospital 2012 DATA BOOK
Legal Authorization of Medical Services
as of April 1, 2012
| Names in laws and regulations | Date of designation | |
|---|---|---|
| Technologically advanced hospital | February 1, 1995 | |
| Hospital accredited by Japan Council for Quality Health Care | June 4, 2010 | |
| Disaster base hospital | March 31, 2007 | |
| AIDS treatment core hospital | August 8, 1996 | |
| Cancer care district liaison hospital | January 31, 2007 | |
| Liver disease care liaison hospital | April 1, 2010 | |
| Center for Maternal - Neonatal Care | April 1, 2012 | |
| Designated medical institution by the Public Assistance Act | November 1, 1980 | |
| Designated emergency hospital | (Ministry of Health and Welfare announcement) | March 30, 1983 |
| Designated medical institution by the Workers' Accident Compensation Insurance Act | July 25, 1957 | |
| Designated medical institution by the Local Public Officers Accident Compensation Act | October 1, 1972 | |
| Designated medical institution by the Act on Medical Care for Atomic Bomb Survivors | April 1, 1972 | |
| Designated medical institution by the Maternal and Child Health Act | (Medical and immature infant care services) | January 22, 1959 |
| Designated medical institution by the Services and Support for Persons with Disabilities Act | (Medical benefits for handicapped children) | April 1, 2006 |
| (Medical benefits for psychiatric outpatients) | ||
| Designated medical institution by the Act on Special Aid to the Wounded and Sick Retired Soldiers | (Medical treatment benefits) | June 24, 1958 |
| Designated medical institution by the Services and Support for Persons with Disabilities Act | (Medical rehabilitation service) | April 1, 2006 |
| Designated medical institution by the Act on Compensation, etc. of Pollution-related Health Damage | September 1, 1974 | |
| Designated tuberculosis care institution | April 1, 2011 | |
| Research Project for Treatment of Specific Chronic Diseases in Children | (Aichi prefecture, etc.) | March 1, 1975 |
| Research Project for Treatment of Specific Diseases | (Aichi prefecture, etc.) | February 1, 1974 |
| Research Project for Congenital Coagulation Factor Disorders | (Aichi prefecture, etc.) | November 1, 1989 |
| Baby and infant medical care | (Aichi prefecture/Nagoya city) | December 1, 1982 |
| Medical care for the disabled | ||
| Medical care for single-mother families | ||
| Medical care for the war-wounded and sick | ||
| General baby medical checkup | October 1, 1978 | |
| General prenatal checkup | February 15, 1986 | |
| Checkup for children with congenital cardiac disease | November 1, 1970 | |
| Advanced medicine | Laparoscopic lymphadenectomy for retroperitoneal node metastasis of genitourinary tumor | July 1, 2006 |
| Epstein-Barr virus quantitation (real-time PCR assay) | February 1, 2009 | |
| Drug resistance DNA testing for anticancer drug therapy | ||
| Angiogenesis therapy by bone marrow cell implantation | August 1, 2009 | |
| Repeated intraperitoneal administration of paclitaxel: Progressive stomach cancer after gastrectomy (only applied to cases with peritoneal metastasis, those with positive peritoneal washing cytology, stage II or III classified as 3 by gross inspection (the longest diameter is at least 8 cm) or classified as 4) | July 1, 2010 | |
| Intraperitoneal and intravenous administration of paclitaxel combined with oral administration of S-1 in patients with peritoneal dissemination or advanced stomach cancer (Only to patients with free tumor cells based on cytology of ascites or cytology of peritoneal lavage) | November 1, 2011 | |
| Distraction osteogenesis using transplantation of cultured bone marrow cells: Skeletal dysplasia (Only to patients with short height or imbalanced lower extremities) | November 1, 2011 | |
| Combination therapy of intravenous administration of pemetrexed and cisplatin: Lung cancer (Excluding squamous lung cancer and small cell lung cancer and only to those patients whose cancer lesions have been completed resected b ased on pathological assessment) | April 1, 2012 | |
